Antimicrobial Essential Oil Combinations to Combat Foot Odour

Abstract

Foot odour (bromodosis) is an embarrassing and perplexing condition mostly caused by bacteria of the Brevibacterium species. Essential oils are a credible option as an affordable treatment of odour and contribute towards antimicrobial efficacy. Therefore, this study sets out to investigate the antimicrobial activity of essential oil combinations against odour-causing bacteria. The broth microdilution method was used to investigate the antimicrobial activity of 119 essential oil combinations, and the fractional inhibitory index was calculated to determine the interactive profile. Combinations that resulted in synergy in 1 : 1 ratios were further evaluated in different concentrations, and isobolograms were plotted to determine the influence of the ratio on overall activity. Numerous combinations could be identified as having synergistic interactions against the Brevibacterium spp. and no antagonism was observed. The combination of Juniperus virginiana (juniper) and Styrax benzoin (benzoin) demonstrated synergy against all three Brevibacterium spp. tested and J. virginiana was the essential oil responsible for the majority of the synergistic interactions. The results reported here confirm the promising potential of the majority of these oils and selected combinations in treating and controlling bromodosis.

Key words

aromatherapy - Brevibacterium spp. - bromodosis - malodour - interactions - essential oils - antimicrobial

• References

• 1 Association AP. Foot odour. Available at http://www.podiatryvic.com.au/Public/Facts4.htm Accessed March 23, 2013
• 2 Gruner E, Pfyffer GE, von Graevenitz A. Characterization of Brevibacterium spp. from clinical specimens. J Clin Microbiol 1993; 31: 1408-1412
• 3 Dixon B. Cheese, toes and mosquitoes. Br Med J 1996; 312: 1105
• 4 Wilson M. Microbial Inhabitants of Humans, their Ecology and Role in Health and Disease. Cambridge, UK: Cambridge University Press; 2005
• 5 Laden K. Antiperspirants and Deodorants: History of major HBA Market. In: Laden K. ed. Antiperspirants and Deodorants. New York: Marcel Dekker; 1999: 1-15
• 6 Kanlayavattanakul M, Lourith N. Therapeutic agents and herbs in topical application for acne treatment. Int J Cosmet Sci 2011; 33: 289-297
• 7 Statista. Size of the global antiperspirant and deodorant market from 2012 to 2023 (in billion U.S. dollars). Available at https://www.statista.com/statistics/254668/size-of-the-global-antiperspirant-and-deodorant-market/ Accessed June 29, 2017
• 8 Semkova K, Gergovska M, Kazandjieva J, Tsankov N. Hyperhidrosis, bromhidrosis, and chromhidrosis: Fold (intertriginous) dermatoses. Clin Dermatol 2015; 33: 483-491
• 9 Exley C. Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimerʼs disease?. Mol Med Today 1998; 4: 107-109
• 10 Darbre PD, Pugazhendhi D, Mannello F. Aluminium and human breast diseases. J Inorg Biochem 2011; 105: 1484-1488
• 11 Bhargava H, Leonard PA. Triclosan: applications and safety. Am J Infect Control 1996; 24: 209-218
• 12 Mass W. Global market for antibiotic resistance and antibiotic technologies to be worth $65.5 billion in 2014. Available at http://www.bccresearch.com Accessed July 17, 2017
• 13 Grandviewresearch. Antibiotics market analysis by drug class (cephalosporins, penicillins, fluoroquinolones, macrolides, carbapenems, aminoglycosides, sulfonamides), by mechanism of action (cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors, folic acid synthesis inhibitors), and segment forecasts to 2024. Available at http://www.grandviewresearch.com Accessed July 17, 2017
• 14 Statista. Size of the global fragrance market from 2012 to 2021 (in billion U.S. dollars). Available at https://www.statista.com/statistics/259221/global-fragrance-market-size/ Accessed July 17, 2017
• 15 Orchard A, van Vuuren SF. Commercial essential oils as potential antimicrobials to treat skin diseases. Evid Based Complement Alternat Med 2017; 2017: 4517971
• 16 Orchard A, Sandasi M, Kamatou GPP, Viljoen A, van Vuuren S. The in vitro antimicrobial activity and chemometric modelling of 59 commercial essential oils against pathogens of dermatological relevance. Chem Biodivers 2017; 14: e1600218 doi:10.1002/cbdv.201600218
• 17 Sellar W. The Directory of essential Oils. London: C. W. Daniel Company Ltd.; 1992
• 18 Lawless J. The illustrated Encyclopedia of essential Oils: the complete Guide to the Use of Oils in Aromatherapy and Herbalism. Massachusetts: Element books; 1995
• 19 Curtis S. Essential Oils. London, UK: Aurum Press; 1996
• 20 Harding J. A Guide to essential Oils. Bath, UK: Parragon; 2002
• 21 Creative A. Just Aromatherapy. Valencia, CA: Top That! Publishing Inc.; 2005
• 22 Clarke S. Essential Chemistry for Aromatherapy. London, UK: Churchill Livingstone; 2008
• 23 Harding J. The essential Oils Handbook. London, UK: Duncan Baird Publishers Ltd.; 2008
• 24 Evans M. Natural Healing: Remedies & Therapies. London, UK: Hermes House; 2010
• 25 Farrer-Halls G. The Aromatherapy Bible: the definitive Guide to using essential Oils. London, UK: Bounty Books; 2011
• 26 Kovac M. A quick Guide to essential Oils. Ljubljana, Slovenia: Aromadelavnice s.p.; 2011
• 27 Meadowbank. Ailments leaflet – find an essential oil for your ailment. 2012.
• 28 Burgess and Finch. Burgess and Finch aromatherapy: patient leaflet. 2013.
• 29 Manetos CM, Pavlidis AN, Kallistratos MS, Tsoukas AS, Chamodraka ES, Levantakis I, Manolis AJ. Native aortic valve endocarditis caused by Brevibacterium epidermidis in an immunocompetent patient. Am J Med Sci 2011; 342: 257-258
• 30 Gruner E, Steigerwalt AG, Hollis DG, Weyant RS, Weaver RE, Moss CW, Daneshvar M, Brown JM, Brenner DJ. Human infections caused by Brevibacterium casei, formerly CDC groups B-1 and B-3. J Clin Microbiol 1994; 32: 1511-1518
• 31 Dass KN, Smith MA, Gill VJ, Goldstein SA, Lucey DR. Brevibacterium endocarditis: a first report. Clin Infect Dis 2002; 35: e20-e21
• 32 Beukinga I, Rodriguez-Villalobos H, Deplano A, Jacobs F, Struelens M. Management of long-term catheter-related Brevibacterium bacteraemia. Clin Microbiol Infect 2004; 10: 465-467
• 33 Kumar VA, Augustine D, Panikar D, Nandakumar A, Dinesh KR, Karim S, Philip R. Brevibacterium casei as a cause of brain abscess in an immunocompetent patient. J Clin Microbiol 2011; 49: 4374-4376
• 34 Talento AF, Malnick H, Cotter M, Brady A, McGowan D, Smyth E, Fitzpatrick F. Brevibacterium otitidis: an elusive cause of neurosurgical infection. J Med Microbiol 2013; 62: 486-488
• 35 Topteny. Top 10 Americaʼs Best-Selling Perfumes. Available at http://www.topteny.com/top-10-americas-best-selling-perfumes/ Accessed July 12, 2017
• 36 de Rapper S, Kamatou G, Viljoen A, van Vuuren S. The in vitro antimicrobial activity of Lavandula angustifolia essential oil in combination with other aroma-therapeutic oils. Evid Based Complement Alternat Med 2013; 2013: 852049
• 37 Orchard A, van Vuuren SF, Kamatou GPP, Viljoen A. The in vitro antimicrobial analysis of commercial essential oil combinations against acne pathogens. Int J Cosmet Sci 2018;
• 38 van Vuuren SF, Viljoen AM. Plant-based antimicrobial studies – methods and approaches to study the interaction between natural products. Planta Med 2011; 77: 1168-1182